Sargassum fusiforme Alginate Relieves Hyperglycemia and Modulates Intestinal Microbiota and Metabolites in Type 2 Diabetic Mice

Sargassum fusiforme alginate (SF-Alg) possess many pharmacological activities, including hypoglycemic and hypolipidemic. However, the hypoglycemic mechanisms of SF-Alg remain unclear due to its low bioavailability. In this study, we evaluated the therapeutic effect of SF-Alg on high-fat diet (HFD)/s...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jian, Wu, Siya, Cheng, Yang, Liu, Qiuhui, Su, Laijin, Yang, Yue, Zhang, Xu, Wu, Mingjiang, Choi, Jong-il, Tong, Haibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398017/
https://www.ncbi.nlm.nih.gov/pubmed/34445047
http://dx.doi.org/10.3390/nu13082887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398017/
https://www.ncbi.nlm.nih.gov/pubmed/34445047
http://dx.doi.org/10.3390/nu13082887

Ejemplares similares